Eye implant showdown: which tiny drain works best for glaucoma?
NCT ID NCT07623434
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two small eye implants, Hydrus and iStent, placed during cataract surgery to help lower eye pressure in people with open-angle glaucoma. 65 patients were followed long-term to see which device worked better and was safer. The goal was to reduce the need for glaucoma medications and protect vision.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hydrus microimplant or iStent microimplant (both are tiny devices placed in the eye during cataract surgery to help drain fluid and lower eye pressure)
What this could lead to
If one device proves better, it could become the preferred option for managing glaucoma during cataract surgery, helping patients maintain vision with fewer eye drops.
What could go wrong
This is a small, completed study (65 people) comparing two existing devices, so it won't lead to a new treatment. Results may not apply to all glaucoma patients, and both devices carry surgical risks like infection or implant misplacement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Military Institute of Medicine - National Research Institute
Warsaw, Mazovian, 04-141, Poland